• New insights on disease mechanisms and etiologies.
  • The latest findings from clinical trials.
  • Innovative outlooks on therapy and prevention.
  • Advances in diagnostic markers.
  • Successful strategies to enhance collaboration between academia and industry.
  • A great opportunity to interact with peers and experts in neurodegenerative diseases.

https://adpd.kenes.com/